Cite
Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial.
MLA
Yamada, Satsuki, et al. “Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial.” Stem Cells Translational Medicine, vol. 13, no. 2, Feb. 2024, pp. 116–24. EBSCOhost, https://doi.org/10.1093/stcltm/szad078.
APA
Yamada, S., Bartunek, J., Povsic, T. J., Cotter, G., Davison, B. A., Edwards, C., Behfar, A., Metra, M., Filippatos, G. S., Vanderheyden, M., Wijns, W., & Terzic, A. (2024). Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial. Stem Cells Translational Medicine, 13(2), 116–124. https://doi.org/10.1093/stcltm/szad078
Chicago
Yamada, Satsuki, Jozef Bartunek, Thomas J Povsic, Gad Cotter, Beth A Davison, Christopher Edwards, Atta Behfar, et al. 2024. “Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial.” Stem Cells Translational Medicine 13 (2): 116–24. doi:10.1093/stcltm/szad078.